NCT07806292
- Conditions
- Unresectable Hepatocellular Carcinoma
- Locations
-
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China
Clinical trial condition
Unresectable Hepatocellular Carcinoma
Explore clinical trials studying Unresectable Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
59 public trials
18 recruiting studies
Unresectable Hepatocellular Carcinoma trial results
NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +168 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Conditions
- Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +13 more
- Locations
-
- Keck Hospital of USC Los Angeles, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT05168163
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Cleveland Clinic Weston Florida Weston, Florida, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
First-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)
NCT07679061
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Mebix. Inc Minato-ku, Tokyo, Japan
- National Cancer Center Hospital East Chiba, Japan
NCT06485466
- Conditions
- Apatinib, Camrelizumab, Transarterial Chemoembolization, +1 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
Recruiting
A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma
NCT07482059
- Conditions
- Unresectable Hepatocellular Carcinoma
- Locations
-
- Study Chair Liu Chang , West China Hospital Chengdu, Sichuan, China
NCT05096715
- Conditions
- Unresectable Hepatocellular Carcinoma
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT07305428
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Queen Mary Hospital Hong Kong